Menu

QH Ubiquinol, sometimes called “Active Q” is the reduced, active form, of CoQ10. The VESIsorb® natural self-assembling colloidal delivery system dramatically improves the QH Ubiquinol absorption and bioavailability in CoQsource® QH.

The pharmacokinetic pilot study in humans comparing QH Ubiquinol to the same QH Ubiquinol in the VESIsorb® delivery system demonstrated an increase of 696% in peak blood levels of Ubiquinol. The relative bioavailability calculated using the area under the curve was also increased by 485%.

Comparison between Standard Kaneka QH vs. VESIsorb® Kaneka QH:
Kaneka QH VESIsorb® Kaneka QH
Kaneka QH 100mg capsule
Kaneka QH 200mg capsule Technology not available*
Patented Kaneka QH Yes Yes
Patented Water soluble Droplets No Yes
Peak Absorption Standard QH 696% increase in peak blood levels (cmax) of Ubiquinol
Relative Bioavailability Standard QH 489% increase in relative bioavailability calculated using the area under the curve (AUC 0-24h)

* The Patented VESIsorb Delivery system improves the loading of the active dose of QH Ubiquinol by 200% compared to other delivery systems can only provide 100mg of QH Ubiquinol in a 1g capsule.

Key VESIsorb advantages depicted in the table include:

  • 100mg VESIsorb® QH capsule is half the size of the competitive QH delivery system making it easier to swallow.
  • Only VESIsorb® can provide 200mg capsule of QH Ubiquinol in contrast to its competitors due to enhanced loading of the active dose by 200%.
  • Only VESIsorb® delivers the active dose in a colloidal droplet delivery system increasing the absorption and bioavailability of QH Ubiquinol producing faster and better results for our consumers.

QH Ubiquinol is described as the “reduced form” of CoQ10. The body must take an extra step to convert CoQ10 (Ubiquinone) to QH Ubiquinol in the body. This is easily done when we are younger but becomes less efficient as we age or our bodies are under stress from disease and other conditions.

QH Ubiquinol, like CoQ10, is not easily absorbed into the body. Once in the body, QH Ubiquinol does not require the conversion step of CoQ10. Both CoQ10 and QH Ubiquinol benefit greatly from the increased absorption and improved bioavailability of the VESIsorb® delivery system.

Comparison between Non-VESIsorb vs. VESIsorb Formula:
QH Ubiquinol without VESIsorb® CoQsource® QH Ubiquinol with VESIsorb®
QH Ubiquinol drops sitting on the water Colloidal droplet formation
Formula does not go into solution 100% in solution
Separation of ingredients Completely homogenous colloidal solution
for optimal absorption!

Compare a standard QH Ubiquinol capsule squeezed into body temperature water to QH Ubiquinol in the VESIsorb® delivery system. Both capsules contain the very same Kaneka QH Ubiquinol yet the difference is dramatic.

A pharmacokinetic pilot study (single oral dose, crossover) in humans comparing QH Ubiquinol to the same QH Ubiquinol in the VESIsorb® delivery system (CoQsource® QH Ubiquinol exclusively from SourceOne) demonstrated an increase of 696% in peak blood levels (cmax) of ubiquinol. The relative bioavailability calculated using the area under the curve (AUC0-24h) was also increased by 485%.

Greater absorption equals maximum health benefits.

VESIsorb® Kaneka QH vs. Standard Kaneka QH Capsules

Corporate Video

VESIsorb®

Vesifact

Newsletter Signup

Sign-up for our monthly newsletter and learn more about new product development updates and scientific research.